title: Prolonged neurological disability following OKT3 therapy for acute renal transplant rejection.
authors.affiliation: Department of Renal Medicine, St. James's University Hospital, Leeds, England.
authors.forename: R F
authors.initials: RF
authors.lastname: Jeffrey
authors.forename: M H
authors.initials: MH
authors.lastname: Johnson
authors.forename: J M
authors.initials: JM
authors.lastname: Bamford
authors.forename: G R
authors.initials: GR
authors.lastname: Giles
authors.forename: A M
authors.initials: AM
authors.lastname: Brownjohn
authors.forename: E J
authors.initials: EJ
authors.lastname: Will
mesh_terms: D000208:Acute Disease; D000328:Adult; D006084:Graft Rejection / Q000628:therapy*; D006801:Humans; D007668:Kidney / Q000502:physiology; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000009:adverse effects* / Q000627:therapeutic use*; D009422:Nervous System Diseases / Q000209:etiology*
chemical_list: D016853:Muromonab-CD3